Aehr Test Systems Form 4 insider transactions
NASDAQ
AEHR TEST SYSTEMS reports a Form 4 filing detailing stock transactions by Director Geoffrey G. Scott.
NASDAQ
Aehr Test Systems CEO Gayn Erickson filed an amendment to correct previously reported beneficial ownership figures and holding structures.
NASDAQ
Didier Wimmers, Executive VP of R&D at Aehr Test Systems, reports a stock purchase under an employee plan.
NASDAQ
Alistair N. Sporck, VP Contactor Business Unit at AEHR TEST SYSTEMS, reported transactions involving company stock on April 2nd, 2026.
NASDAQ
AEHR TEST SYSTEMS CFO Chris Siu reported transactions involving common stock, including purchases through an employee stock purchase plan and shares withheld for tax obligations.
NASDAQ
Alberto Salamone, EVP, PPBI BUSINESS at AEHR TEST SYSTEMS, reported stock transactions including purchases and tax withholdings.
NASDAQ
Vernon Rogers, Exec VP of Sales & Mktg. at Aehr Test Systems, reports transactions involving common stock and restricted stock units.
NASDAQ
Donald P. Richmond II, CTO of AEHR Test Systems, reported stock transactions including purchases and tax withholdings.
NASDAQ
Gayn Erickson, President and CEO of Aehr Test Systems, reports stock transactions including purchases and withholding for tax obligations.
NASDAQ
Adil Engineer, Chief Operating Officer of Aehr Test Systems, reports stock transactions including purchases and tax withholdings.
NASDAQ
An AEHR Test Systems executive reported a routine transaction involving the withholding of shares for tax obligations upon restricted stock unit vesting.
NASDAQ
AEHR Test Systems CFO Chris Siu reported a disposition of 368 common shares for tax withholding purposes related to restricted stock unit vesting.
NASDAQ
Aehr Test Systems Director Rhea J. Posedel reported the sale of 13,998 shares of common stock at $30.0151 per share, effective February 13, 2026, under a pre-arranged 10b5-1 plan.
NASDAQ
Aehr Test Systems' VP of Contactor Business Unit, Alistair N Sporck, sold 3,000 shares of common stock for approximately $82,749 as part of a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
AEHR Test Systems Director Howard T. Slayen reported planned future gifts of 15,000 common shares to family trusts effective February 4, 2026.
NASDAQ
An AEHR Test Systems executive had 234 shares withheld for tax obligations upon restricted stock unit vesting, maintaining a beneficial ownership of 76,906 shares.
NASDAQ
Aehr Test Systems VP Alistair N Sporck reported a disposition of 152 common shares for tax withholding purposes related to restricted stock unit vesting, effective January 27, 2026.
NASDAQ
Vernon Rogers, AEHR Test Systems' Exec VP of Sales & Marketing, had 160 shares withheld for tax obligations upon restricted stock unit vesting, with 177,206 shares beneficially owned post-transaction.
NASDAQ
AEHR Test Systems' CTO, Donald P. Richmond II, reported a routine disposition of 117 common shares for tax withholding purposes at a price of $27.75 per share.
NASDAQ
AEHR Test Systems CEO Gayn Erickson reported a pre-planned transaction involving the withholding of 820 shares of common stock to cover tax obligations related to restricted stock unit vesting.
NASDAQ
Aehr Test Systems' Chief Operating Officer, Adil Engineer, had 163 shares withheld for tax obligations upon the vesting of restricted stock units.
NASDAQ
Aehr Test Systems Director Laura Oliphant sold 4,546 shares of common stock on January 22, 2026, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Aehr Test Systems VP Alistair N Sporck reported an anticipated disposition of 387 common shares at $28.81 on January 19, 2026, to cover tax obligations from restricted stock unit vesting.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at AEHR Test Systems, reported the withholding of 464 common shares for tax obligations related to restricted stock unit vesting.
NASDAQ
AEHR Test Systems' CTO, Donald P. Richmond II, had 343 shares withheld for tax obligations related to restricted stock unit vesting on January 14, 2026.
NASDAQ
AEHR Test Systems CEO Gayn Erickson reported a routine transaction involving shares withheld for tax obligations upon restricted stock vesting.
NASDAQ
Aehr Test Systems' VP of Engineering, Donald P. Richmond II, filed an amended Form 4 to correct previously reported share withholding and beneficial ownership figures.
NASDAQ
AEHR Test Systems' President and CEO, Gayn Erickson, reported a routine transaction involving shares withheld for tax obligations upon the vesting of restricted stock units.
NASDAQ
Vernon Rogers, AEHR's Executive VP of Sales & Marketing, reported a routine withholding of 576 common shares for tax obligations related to restricted stock unit vesting.
NASDAQ
Aehr Test Systems' CTO, Donald P. Richmond II, reported a disposition of 576 common shares for tax withholding purposes, maintaining a beneficial ownership of 213,587 shares.